Who owns CONNECT BIOPHARMA HLDGS LTD?

Tip: Access positions for across all investors

Analyze quarterly positions in Connect Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Connect Biopharma Hldgs stock

Who bought or sold CONNECT BIOPHARMA HLDGS LTD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BML Capital Management 2.1M $3.6M 0% Mar 2024
 View chart
BlackRock 1.0M $1.8M -8% Mar 2024
 View chart
UBS O'Connor 511k $889k 100% Mar 2024
 View chart
Geode Capital Management 28k $49k 47% Mar 2024
 View chart
Commonwealth Equity Services 20k $35k 100% Mar 2024
 View chart
Keudell/Morrison Wealth Management 20k $34k 76% Mar 2024
 View chart
Rhumbline Advisers 17k $29k 0% Mar 2024
 View chart
Two Sigma Investments 11k $19k -5% Mar 2024
 View chart
Jpmorgan Chase & Co 121.00 $210.999800 0% Mar 2024
 View chart
Simplex Trading 81.00 $0 100% Mar 2024
 View chart
Qube Research & Technologies 46.00 $79.998600 0% Mar 2024
 View chart

Who sold out of Connect Biopharma Hldgs?

Fund or Company Name Date Sold Shares Held Valued At
RA Capital Management Dec 2023 3.1M $3.6M
Adage Capital Partners GP Sep 2023 650k $532k
Two Sigma Securities Dec 2023 12k $15k
Royal Bank of Canada Dec 2023 449.00 $1.0k